More on NPHC
Data
Financials
Upcoming Events
News
Click line-items for a historical chart and %
| Net sales | 70.49K |
| Cost of sales | 9.93K |
| Gross profit | 60.56K |
| Selling, general and administrative - including stock based compensation of $185,583, $398,750, $398,083 and $505,000 respectively | 566.58K |
| Research and development | |
| Interest expense | -59.45K |
| Total costs and expenses | 566.58K |
| Net loss from Operations | -506.01K |
| Derivative Income | |
| Net Loss | -644.02K |
| Loss per common share (in dollars per share) | 0 |
| Weighted average common shares outstanding (in shares) | |
Entities mentioned with NPHC
- Definitive Agreement | View Related Stories »
- NT 10-Q | View Related Stories »
- 13D | View Related Stories »
- FDA | View Related Stories »
- 13G | View Related Stories »
- Twitter | View Related Stories »
- PDUFA | View Related Stories »
- Show More...
